Full Text View
Tabular View
No Study Results Posted
Related Studies
Comperative Trial Between an Accommodative Iol and Monofocal Iol
This study is not yet open for participant recruitment.
Verified by Shaare Zedek Medical Center, January 2008
First Received: January 17, 2008   Last Updated: January 29, 2008   History of Changes
Sponsored by: Shaare Zedek Medical Center
Information provided by: Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00604305
  Purpose

a comparison of two intraocular lenses in regard of accommodative power.


Condition Intervention
CATARACT SURGERY
Device: Acrysof
Device: Acuity's AIOL

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Parallel Assignment
Official Title: A Randomized Single Blind Comparative Study of the Acuity's C-Well Accommodating Intra Occular Lens (AIOL) Against Alcon's Acrysof

Resource links provided by NLM:


Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • distance and near visual acuity [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • centration pco [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 20
Study Start Date: March 2008
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Acrysof: Active Comparator
Routine monofocal IOL
Device: Acrysof
Monofocal IOL
Acuity's AIOL: Active Comparator
Accomodaing IOL
Device: Acuity's AIOL
Accommodating IOL

Detailed Description:

A new accomodating IOL (Acuity Ltd, Israel) will be compared with Alcon's Acrysof for 1 year for visual acuity and distance and near best corrected visual acuity.

  Eligibility

Ages Eligible for Study:   30 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 30 and 65
  • Required cataract operation in one or both eyes
  • BCVA potetial at least 20/30
  • Clear intraoccular media
  • Willing to participate in study as evidenced by signing a written Informed Consent

Exclusion Criteria:Main

  • Prior surgery at the selected eye
  • No light perception or poor potential for improvement
  • Phacodonesis and damaged zonules
  • Pupil size at least 6 mm.
  • History of uveitis
  • Macular disease decreasing vision below 20/30
  • Amblyopia
  • Axial length shorter than 21 mm and longer than 25 mm
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: shaare zedek medical center ( yaacov rozenman head of eye department )
Study ID Numbers: 6666476CTIL, Rozenman-CWPMS001
Study First Received: January 17, 2008
Last Updated: January 29, 2008
ClinicalTrials.gov Identifier: NCT00604305     History of Changes
Health Authority: Israel: Ministry of Health

Study placed in the following topic categories:
Eye Diseases
Cataract
Lens Diseases

Additional relevant MeSH terms:
Eye Diseases
Cataract
Lens Diseases

ClinicalTrials.gov processed this record on September 10, 2009